Thank you, @eitchan for your excellent coverage of the Spike Prion! 💪@P_McCulloughMD @NicHulscher @McCulloughFund @neo7bioscience

The Best Business and Health Care Decision for America Pull mRNA products from public use. Now. President Trump and Secretary Kennedy must not waver with Pfizer, Moderna, Merck, or anyone else selling mRNA gene products. The platform is the problem. Hold the line. Substack Article Link: johncatanzaro.substack.com/p… @P_McCulloughMD @NicHulscher @MaryBowdenMD @HHSGov @SecKennedy @POTUS45 @FDA @CDCgov @AmerHlthFreedom

💯💪

💪SHUT DOWN = RIGHT DIRECTION ❌SUPPORT = WRONG DIRECTION! "The Department of Health and Human Services (HHS) on Monday reaffirmed its support for 'mRNA research'... The HHS spokeswoman delivering that response, Emily Hilliard, previously personally provided communications services to Pfizer through Hill & Knowlton Strategies, according to her federal financial disclosure. Her Hill & Knowlton tenure ran from November 2021 through April 2023, during the COVID-19 vaccine era.

Journal of Independent Medicine Features Global Scientific Perspectives in New Issue Volume 2, No. 5 brings together U.S. and international researchers to examine emerging questions in medicine, including a new reanalysis of FDA data co-authored by Dr. Peter McCullough Washington, D.C. (Sept 22, 2026) — The Independent Medical Alliance (IMA) today announced the publication of Volume 2, No. 5 of the Journal of Independent Medicine (JIM), continuing the journal’s growing international reach and its mission to advance rigorous, conflict-free scientific inquiry through collaboration among physicians, researchers, and experts from around the world. This latest issue reflects an increasingly global scientific community examining health challenges that extend far beyond national borders. Its ten articles span metabolic health and fasting, cancer biology, COVID-19 public health policy, pharmacovigilance, vaccine regulatory science, cardiovascular pathology, dermatology, medical publishing, and freedom of scientific discourse. “Medicine has always advanced when physicians and scientists learn from one another, and today that conversation must be global,” said Joseph Varon (@joevaron), MD, Editor-in-Chief of the Journal of Independent Medicine (@JIndepMed) and President and Chief Medical Officer of IMA. “The challenges facing patients do not stop at borders, and neither should scientific inquiry. As IMA continues to expand its international relationships, the Journal gives experts from different countries, specialties, and clinical environments a place to bring their observations and research into the same conversation—grounded in evidence, transparency, and a shared commitment to patients.” One of the issue’s featured original investigations is “Reanalysis of FDA Clinical Data for mFLUSIVA (mRNA-1010),” by Nicolas Hulscher (@NicHulscher), Peter A. McCullough, MD (@P_McCulloughMD), and John A. Catanzaro (@Docjohnc). The authors reexamine regulatory and clinical-trial data from Moderna’s (@moderna_tx) recently approved mRNA influenza vaccine, using absolute benefit-risk measures to evaluate efficacy, adverse events, evidentiary basis and question the vaccine’s overall benefit-risk profile and argue that their findings warrant further scrutiny of its continued licensure. The breadth of the new issue also underscores an important distinction at the heart of IMA’s approach to scientific independence: independent medicine does not mean working alone. “Scientific independence should expand the conversation, not narrow it,” Varon added. “When researchers with different backgrounds and perspectives can examine evidence openly, challenge assumptions, and publish findings without commercial or political pressure, science becomes stronger. That is what Honest Medicine is about, and it is exactly the kind of international scientific community we want this Journal to continue building.” Read the full statement and find Volume 2, No. 5 and all previous issues of the Journal of Independent Medicine - links below. 🔽

The evidence has been analyzed, the extreme safety hazards have been documented, and the findings have now been peer-reviewed and published. NO excuses remain. mFLUSIVA must be removed from the market. journalofindependentmedicine…

BREAKING: Our FDA Data Reanalysis Demanding MARKET WITHDRAWAL of Moderna’s mRNA Flu Shot Is Now PEER-REVIEWED and PUBLISHED The FDA’s own data now sit in the peer-reviewed record showing a 155% higher risk of UNEXPLAINED DEATH, a 515% higher risk of DISABLING REACTIONS, and an EXTREME risk-benefit imbalance. When putting benefits and harms on the same scale, we found that it’s a form of HUMAN SACRIFICE to administer mFLUSIVA. To theoretically prevent ONE flu hospitalization: 2 people suffer unexplained deaths. 278 people suffer a disabling Grade 3 reaction. 3,798 people suffer an adverse event. Our peer-reviewed study now provides Secretary Kennedy substantial scientific firepower to fulfill the demands of his supporters and HALT mRNA technology. Regulators have NO legitimate basis to ignore these horrific data. Market removal of mFLUSIVA is now REQUIRED to protect public safety.

Our paper released this month demonstrates the dangers of allowing Spike protein to build up in the body after mRNA vaccination. The rationale for McCullough Protocol Base Spike Detoxification with exogenous enzymes is solid. In my clinical experience, Spike syndromes do not resolve without it. @McCulloughFund @NicHulscher @neo7bioscience @Docjohnc 2026 John A. Catanzaro, NMD, PhD, Peter A. McCullough, MD, MPH, Nicolas Hulscher, MPH. International Journal of Innovative Research in Medical Science

Even though COVID-19 boosters genetically code for a milder S-protein variant, the accumulation of Spike in tissues is unnatural; intensifying with each shot it likely leads to future proteostatic collapse. Courtesy Catanzaro et al 2026. @McCulloughFund @stevegrubershow @RealAmVoice @NicHulscher @Docjohnc @neo7bioscience @ijirms

Customized To Clear Cancer! Podcast Link, Listen In: johncatanzaro.substack.com/p… Dr. John Catanzaro is a pioneering leader in precision molecular medicine, specializing in personalized peptide engineering, OMICS-driven bioinformatics therapeutics, and signal-based molecular interventions. He earned his Doctorate of Naturopathic Medicine from Bastyr University in 1995 and a Doctorate of Theology in Science and Medical Ethics from Bethany Divinity Seminary in 2012. Dr. Catanzaro is a Co-founder of Neo7Bioscience, which was born of his desire to help critically ill cancer patients who have exhausted traditional treatment options and are seeking alternatives. He is a relentless advocate for next-generation patient-specific therapeutics. His work bridges the frontier of cutting-edge science and transformative clinical applications, shaping the future of precision medicine through intelligent molecular signaling and redefining personalized healthcare, while adhering to the highest legal and ethical business standards.

CDC data reveal babies are dying at rates 50% above normal since women were mass-injected with mRNA gene therapies. TRANSGENERATIONAL fatal adverse events are a serious concern as studies are now finding mRNA and spike protein inside placentas and fetal cells. It’s time for criminal charges.

Withdrawing COVID-19 mRNA vaccines is only the beginning. The broader and more urgent population-level danger is the mRNA platform itself—the engine powering an expanding pipeline of genetically engineered products. Immediate suspension, independent investigation, and the strongest black-box warning are imperative. nitter.net/docjohnc/status/209999…

(PEER-REVIEWED STUDY LINK) Recombinant SARS-CoV-2 Spike Protein and Prion-Like Domains: Persistent Cross-Seeding of Amyloid-β and Tau, Transcriptional Instability, and Tissue Dysfunction: ijirms.in/index.php/ijirms/a…

BREAKING: Our study revealing that spike protein drives PRION-LIKE protein misfolding has now been PEER-REVIEWED and PUBLISHED. BILLIONS of people were exposed to LAB-MADE spike protein containing PRION-LIKE DOMAINS capable of promoting dangerous protein clumping. This helps explain spike-associated CREUTZFELDT-JAKOB DISEASE, amyloid microclot formation, large WHITE FIBROUS CLOTS, and progressive multi-organ damage. Those responsible must be held to account. @Docjohnc @P_McCulloughMD

Withdrawing COVID-19 mRNA vaccines is only the beginning. The broader and more urgent population-level danger is the mRNA platform itself—the engine powering an expanding pipeline of genetically engineered products. Immediate suspension, independent investigation, and the strongest black-box warning are imperative.

Precision oncology is moving beyond the idea of matching one mutation to one drug. A new case report in Naturopathic Doctor News & Review explores how serial molecular profiling can help clinicians better understand how metastatic colorectal cancer changes over time — and how treatment strategies may need to evolve alongside that biology.The case integrated genomics, metabolism, nutrition, immune-directed strategies, natural medicines, repurposed pharmaceuticals, and conventional oncology. A patient-specific neoantigen peptide immunotherapy designed by Neo7 Biosciences was also incorporated as part of the broader multidisciplinary strategy.Follow-up molecular testing showed substantial reductions in several established circulating tumor variants. Importantly, the article does not attribute those changes to any single therapy, but instead highlights the value of ongoing molecular surveillance and individualized, adaptive care.The bigger takeaway: cancer biology is not static, and precision medicine shouldn’t be either. Read the full article: The Future of Precision Oncology: Molecular Profiling and Personalized Treatment in Metastatic Colorectal Cancer. Read here: ndnr.com/precision-naturopat…

We’re proud to share a powerful new conversation featuring our CEO, Dr. John Catanzaro, NMD, PhD, on the Radical Remission Project’s Stories That Heal podcast. 🎙️ In this episode, Dr. Catanzaro shares the vision behind Neo7 Bioscience, his commitment to advancing precision molecular medicine, and the work driving our mission to create more personalized approaches for patients navigating complex health challenges. His leadership continues to shape the future of Neo7 — bringing together molecular intelligence, patient-specific therapeutics, peptide engineering, and signal-based interventions with one goal in mind: helping move medicine toward a more precise, individualized future. We’re grateful to the Radical Remission Project for giving Dr. Catanzaro the opportunity to share more about his journey, his perspective, and the mission behind the work we do every day at Neo7. 🎧 Listen to the full episode at the link in our bio or wherever you listen to podcasts. @RadicalRemiss @Docjohnc open.spotify.com/episode/6Yd…

You don’t have to accept “this is just your new normal.” When you’ve been searching for answers, trying different approaches, and still don’t feel like yourself, the hardest part can be not knowing what to do next. The NEO7 Spike Expo Program takes a more personalized approach — looking deeper at the molecular signaling that may be influencing your health and giving your provider information to help guide your next steps. Because you deserve more than guessing. You deserve an approach built around you. If you’re ready to explore what’s next, connect with a NEO7 provider, find a telehealth option, or introduce your current provider to NEO7. Don’t stop searching for answers. Your health is worth fighting for.

Exciting news from Neo7 Bioscience! We're thrilled to welcome Dr. Michael Robinson and Dr. Jorge Morales to our Clinical & Educational Services team as Consultants and Advisors. Between integrative oncology, functional medicine, and molecular medicine, these two bring the kind of depth that pushes precision medicine forward — for the providers we train and the patients they serve. 👉 Swipe to meet them. Interested in working with our growing clinical team, or want to learn more about what this means for Neo7? Send us a DM — we'd love to connect. 📩

Something exciting is coming to Neo7. 👀 We’re growing our Clinical & Educational Services team and bringing new expertise into the Neo7 community. More details—and new team member introductions—coming soon. Stay tuned. 🌿